iprolepsis.bsky.social
🏥 iPROLEPSIS: Psoriatic arthritis inflammation explained through multi-source data analysis guiding a novel personalised digital care ecosystem⚕️ iPROLEPSIS receives funding from the European Union under Grant Agreement No. 101095697.
👤 Joined on 14 February 2025
Followers
Following
Total Posts
@iprolepsis.bsky.social🗞️ The 12th @iprolepsis.bsky.social Newsletter is out. New publication, Learning Hub resources, PsA quizzes, and updates from recent project activities. Read it here: www.iprolepsis.eu/_files/ugd/9... #iPROLEPSIS #PsoriaticArthritis #DigitalHealth #HorizonEU
Show PostDr David Lyreskog presented "Parkinson's Disease Management in the Era of AI: Navigating the Living Systems of Trust and Care" at the Future of Psychiatry event, University of Oxford. The poster positions @aiprognosis.bsky.social as a case for reimagining Trustworthy AI. #ParkinsonsDisease
Show PostAnother @iprolepsis.bsky.social highlight from #DSAI2026: Prof. Leontios Hadjileontiadis presented tri-project insights from @iprolepsis.bsky.social, @aiprognosis.bsky.social and REBECCA on multimodal digital phenotyping. #DigitalBiomarkers #AIinHealth
Show Post@aiprognosis.bsky.social was represented at #DSAI2026. Prof. Leontios Hadjileontiadis moderated the Opening Panel and presented cross-project insights on multimodal digital phenotyping from @aiprognosis.bsky.social, @iprolepsis.bsky.social and and REBECCA. #DigitalBiomarkers #AIinHealth
Show Post🌷 11 April – World Parkinson’s Day From predictive models to prototype apps, clinical studies and co-creation, @aiprognosis.bsky.social is working on new digital health tools for Parkinson’s screening and care. youtu.be/Dc4nImI9mKY #WorldParkinsonsDay #ParkinsonsDisease #DigitalHealth #HorizonEurope
Show Post